Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Archives of Internal Medicine

• Publication date

  2005-05-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHINTE.165.10.1179PMID 15911733
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Incident reporting and patient safety

  2007cited by this paper
• The metabolic effects of lopinavir/ritonavir in HIV-negative men

  2004cited by this paper
• Risk of metabolic abnormalities in patients infected with HIV receiving antiretroviral therapy that contains lopinavir-ritonavir.

  2004cited by this paper
• Direct interference of HIV protease inhibitors with pancreatic β-cell function

  2004cited by this paper
• Direct interference of HIV protease inhibitors with pancreatic beta-cell function.

  2004cited by this paper
• A modified poisson regression approach to prospective studies with binary data.

  2004cited by this paper
• The Effect of HAART and HCV Infection on the Development of Hyperglycemia Among HIV‐Infected Persons

  2003cited by this paper
• Incidence of and Risk Factors for Lipoatrophy (Abnormal Fat Loss) in Ambulatory HIV-1-Infected Patients

  2003cited by this paper
• Follow-up report on the diagnosis of diabetes mellitus.

  2003cited by this paper
• Impact of HIV infection and HAART on serum lipids in men.

  2003cited by this paper
• Protease Inhibitor Use and the Incidence of Diabetes Mellitus in a Large Cohort of HIV‐Infected Women

  2003cited by this paper
• Risk factors for the HIV‐associated lipodystrophy syndrome in a closed cohort of patients after 3 years of antiretroviral treatment

  2002cited by this paper
• Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy.

  2002influential reference
• Ischemic cardiovascular disease in persons with human immunodeficiency virus infection.

  2002cited by this paper
• Guidelines for Using Antiretroviral Agents among HIV-Infected Adults and Adolescents: The Panel on Clinical Practices for Treatment of HIV*

  2002cited by this paper
• Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy.

  2001cited by this paper
• Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis

  2001cited by this paper
• The agreement between self-reporting and clinical diagnosis for selected medical conditions among the elderly in Taiwan.

  2000cited by this paper
• Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study.

  2000cited by this paper
• Hyperglycemia Associated with Protease Inhibitors in an Urban HIV-Infected Minority Patient Population

  2000cited by this paper
• The Mechanism of Insulin Resistance Caused by HIV Protease Inhibitor Therapy*

  2000cited by this paper
• Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study.

  1999cited by this paper
• Mucocutaneous Lesions in the Behcet Syndrome

  1998influential reference
• Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV‐1‐infected patients

  1998influential reference
• Impaired glucose tolerance and protease inhibitors.

  1998cited by this paper
• The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants.

  1987cited by this paper
• Evaluation of glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides in the hexokinase method for determining glucose in serum.

  1974influential reference

• Type 2 diabetes in people living with HIV: epidemiology, mechanisms, sex differences and early-life determinants.

  2026cites this paper
• Mitochondrial DNA Variation, Antiretroviral Therapy, and Incidence of Diabetes Among Men With and Without HIV

  2026cites this paper
• Prevalence and Factors Associated With Hyperglycemia Among Patients on Dolutegravir-Based Antiretroviral Therapy: A Cross-Sectional Study From Central Uganda.

  2026cites this paper
• Coronary Artery Disease and Human Immunodeficiency Virus.

  2025cites this paper
• The Association between HIV and Obesity: Causes, Comorbidities and Future Directions

  2025cites this paper
• Deciphering the Association: Critical HDL-C Levels and Their Impact on the Glycation Gap in People Living with HIV

  2025cites this paper
• Inflammation among kidney transplant donors with and without HIV: Multicenter HOPE in Action Consortium.

  2025cites this paper
• A Distinct Form of Subcutaneous Fat Fibrosis is Linked to Insulin Resistance in People with HIV.

  2025cites this paper
• Burden of Chronic Health Conditions Among People With HIV and Common Non-AIDS-Defining Cancers.

  2025cites this paper
• Characterization and stratification of risk factors of stroke in people living with HIV: A theory-informed systematic review

  2025cites this paper
• Association between HIV infection and type 2 diabetes mellitus: global incidence, prevalence, and risk factors – a systematic review and meta-analysis

  2025cites this paper
• No Genetic Causal Relationship Between HIV Infection and Insulin Resistance, Diabetes: A Bidirectional Mendelian Randomization Analysis

  2025cites this paper
• Persistent inflammatory activation in people living with HIV. Involvement in atherosclerosis

  2025cites this paper
• Cardiovascular Outcomes After Acute Coronary Syndrome in Persons Living with HIV: A Scoping Review

  2025cites this paper
• Pathogenesis of HIV-Associated Metabolic Syndrome and Clinical Management Recommendations

  2025cites this paper
• The Impact of Gut Microbial Metabolomics on Type 2 Diabetes Development in People Living with HIV

  2025cites this paper
• The Role of Clinical Pharmacists in HIV Treatment and Prevention: A Scoping Review of Real‐World Evidence

  2025cites this paper
• Hyperglycemia and its associated factors among people living with HIV on dolutegravir-based antiretroviral therapy in Ethiopia: a cross-sectional study

  2025cites this paper
• Comparative Analysis of Inflammatory and Metabolic Biomarkers Among Patients with HIV, COVID-19, Type 2 Diabetes Mellitus, and PCOS at University Teaching Hospitals in Nigeria

  2025cites this paper
• Leukocyte count and new‐onset diabetes mellitus in people with HIV: A longitudinal study

  2025cites this paper
• Awareness and perceived risk of type 2 diabetes among older adults with HIV: results from a qualitative study

  2025cites this paper
• From Weight Gain to Heart Strain: HIV Antiretroviral Adverse Effect Management in Primary Care

  2025cites this paper
• From Steatosis to Immunosenescence: The Impact of Metabolic Dysfunction on Immune Aging in HIV and Non-HIV Populations

  2025cites this paper
• HIV-associated kidney diseases: progress, gaps, and future directions

  2025cites this paper
• Metabolic dysfunction-associated steatotic liver disease in people with HIV

  2025cites this paper
• Prevalence of Diabetes Mellitus Among People Living With HIV and Receiving Antiretroviral Therapy at Muhimbili National Hospital in Tanzania

  2025cites this paper
• Perceptions and management of diabetes and obesity among people living with HIV in Côte d’Ivoire: a qualitative study

  2025cites this paper
• Prevalence of Hyperglycaemia and Associated Factors Among People Living with HIV in Eastern Uganda: A Descriptive Cross-sectional Study

  2024cites this paper
• Evaluating the Glycemic Effects of Dolutegravir and Its Predictors Among People With Human Immunodeficiency Virus in Uganda: A Prospective Cohort Study

  2024influential citation
• Incidence of prostate cancer in Medicaid beneficiaries with and without HIV in 2001–2015 in 14 states

  2024cites this paper
• SHBG, Free Testosterone, and Type 2 Diabetes Risk in Middle-aged African Men: A Longitudinal Study

  2024cites this paper
• Diabetes Risk Factors in People With HIV Receiving Pitavastatin Versus Placebo for Cardiovascular Disease Prevention

  2024cites this paper
• Prevalence of Diabetes Mellitus in People Living With HIV in Dammam, Saudi Arabia

  2024cites this paper
• Incidence of prostate cancer in Medicaid beneficiaries with and without HIV in 2001–2015 in 14 states

  2024cites this paper
• Emerging roles of senolytics/senomorphics in HIV-related co-morbidities.

  2024cites this paper
• Cardiovascular Risk Estimation Is Suboptimal in People With HIV

  2024cites this paper
• The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: A modeling study

  2024cites this paper
• Associations between social determinants of health and comorbidity and multimorbidity in people of black ethnicities with HIV

  2024cites this paper
• The Incidence of Type 2 Diabetes Mellitus and Weight Gain in People Living with HIV Receiving a Dolutegravir-Based Antiretroviral Therapy in Addis Ababa, Ethiopia: A Pilot Single-Arm Historical Cohort Study

  2024cites this paper
• Integrase strand transfer inhibitor (INSTI) related changes in BMI and risk of diabetes: a prospective study from the RESPOND cohort consortium.

  2024cites this paper
• The Potential of Clostridium butyricum to Preserve Gut Health, and to Mitigate Non-AIDS Comorbidities in People Living with HIV

  2024cites this paper
• Glycemic Control in Patients Living With HIV Initiated on Integrase Inhibitor–Based Three-Drug Antiretroviral Therapy

  2024cites this paper
• Efficacy and Safety of Bariatric Surgery in Dutch People Living with HIV: a Retrospective Matched Cohort Analysis

  2024cites this paper
• The changing landscape of HIV-associated kidney disease

  2024cites this paper
• Diabetes mellitus and associated risk factors among HIV infected patients on HAART

  2024influential citation
• LGBTQ+ cardiovascular health equity: a brief review

  2024cites this paper
• Diagnosis and Risk Factors of Prediabetes and Diabetes in People Living with HIV- Evaluation of Clinical and Microbiome Parameters.

  2024cites this paper
• HIV-Associated Cardiovascular Disease Pathogenesis: An Emerging Understanding Through Imaging and Immunology.

  2024cites this paper
• Patient and clinician preferences for diabetes management among older adults with co-morbid HIV: A qualitative exploration

  2024cites this paper
• An update on drug–drug interactions in older adults living with human immunodeficiency virus (HIV)

  2024cites this paper
• Evolving mechanisms and presentations of cardiovascular disease in people with HIV: implications for management

  2024cites this paper
• The impact of diabetes mellitus on HIV virologic control: results of the MACS/WIHS combined cohort study

  2024cites this paper
• Metabolic causes of liver disease among adults living with HIV from low‐ and middle‐income countries: a cross‐sectional study

  2024cites this paper
• Risk factors for progression from prediabetes to diabetes among older people with HIV

  2024cites this paper
• TERT single nucleotide polymorphism rs2736098 but not rs2736100 is associated with telomere length in HIV-infected patients on cART

  2024cites this paper
• Optimizing cardiometabolic risk in people living with human immunodeficiency virus: A deep dive into an important risk enhancer

  2024influential citation
• Viruses and Endocrine Diseases

  2023cites this paper
• Association Between Metformin Use and Cognitive and Physical Function in Persons with HIV and Diabetes

  2023cites this paper
• Comorbidities and New Onset of Type 2 Diabetes Mellitus among Women Living with HIV Receiving Antiretroviral Therapy in Lagos, Nigeria

  2023cites this paper
• The role of TEMRA cell-mediated immune senescence in the development and treatment of HIV disease

  2023cites this paper
• COVID-19: Diabetes Perspective—Pathophysiology and Management

  2023cites this paper
• Risk indicators for oral ulcers among people living with HIV during the first wave of the pandemic: a cross sectional study

  2023cites this paper
• HIV and type 2 diabetes: An evolving story

  2023cites this paper
• A Qualitative Exploration of Perceived Medication Adherence Determinants Conducted Among Older Adults with HIV and Type 2 Diabetes Mellitus

  2023cites this paper
• The pathogenesis of obesity in people living with HIV

  2023cites this paper
• Interactions of alcohol and combination antiretroviral (cART) drug in diabetic male Sprague Dawley rats: Hippocampal perturbations and toxicosis

  2023cites this paper
• Management of Type 2 Diabetes Mellitus and Kidney Failure in People with HIV-Infection in Africa: Current Status and a Call to Action

  2023influential citation
• Risk factors for progressing to severe COVID-19 among people living with HIV in Japan: A hospital claims database study.

  2023cites this paper
• Role of fatty liver in the epidemic of advanced chronic liver disease among people with HIV: protocol for the Canadian LIVEHIV multicentre prospective cohort

  2023cites this paper
• Significant loss of retinal nerve fibre layer and contrast sensitivity in people with well controlled HIV disease: implications for aging with HIV

  2023cites this paper
• Comparison of five different risk scores to predict incident type 2 diabetes in the Swiss HIV cohort study

  2023cites this paper
• Metformin Treatment Leads to Increased HIV Transcription and Gene Expression through Increased CREB Phosphorylation and Recruitment to the HIV LTR Promoter

  2023cites this paper
• Prevalence of Cardiometabolic Disease Risk Factors in People With HIV Initiating Antiretroviral Therapy at a High-Volume HIV Clinic in Kampala, Uganda

  2023cites this paper
• Perceptions of multiple chronic conditions and coping strategies among migrants from Sub-Saharan Africa living in France with diabetes mellitus and HIV: An interview-based qualitative study

  2023cites this paper
• Metformin for the prevention of diabetes among people with HIV and either impaired fasting glucose or impaired glucose tolerance (prediabetes) in Tanzania: a Phase II randomised placebo-controlled trial

  2023cites this paper
• Prevalence and characteristics of metabolic syndrome and its components among adults living with and without HIV in Nigeria: a single-center study

  2023cites this paper
• Evaluation of some immune and inflammatory responses in diabetes and HIV co-morbidity

  2023cites this paper
• Metabolic Syndrome Among Human Immunodeficiency Virus Patients on Antiretroviral Therapy Attending Clinic at a District Hospital in Ghana

  2023cites this paper
• Distinct patterns of fasting plasma glucose and lipid profile levels over time in adults tested positive for HIV on HAART in Shanghai, China, revealed using growth mixture models

  2023cites this paper
• Incident diabetes in course of antiretroviral therapy

  2023cites this paper
• Exploring the Relation Between Diabetes and HIV: A Narrative Review

  2023cites this paper
• HIV and chronic lung disease

  2022cites this paper
• Divergent effects of HIV reverse transcriptase inhibitors on pancreatic beta-cell function and survival: Potential role of oxidative stress and mitochondrial dysfunction.

  2022cites this paper
• Nucleoside Reverse Transcriptase Inhibitors Are the Major Class of HIV Antiretroviral Therapeutics That Induce Neuropathic Pain in Mice

  2022cites this paper
• HIV in Primary Care: Case Study of Common Chronic Comorbidities

  2022cites this paper
• Insulin resistance in people living with HIV is associated with exposure to thymidine analogues and/or didanosine and prior immunodeficiency

  2022cites this paper
• Prevalence and predictors of glucose metabolism disorders among People Living with HIV on combination antiretroviral therapy

  2022influential citation
• Effect of Dolutegravir on Plasma Glucose Among Human Immunodeficiency Virus Patients in a Community Health Center Setting

  2022cites this paper
• Early detection of poor glycemic control in patients with diabetes mellitus in sub-Saharan Africa: a cohort study in Mozambique

  2022cites this paper
• Tropical medicine and diabetes: an integrative paradigm

  2022cites this paper
• Diabetes in HIV: the Link to Weight Gain

  2022cites this paper
• Diabetes mellitus is associated with declines in physical function among men with and without HIV

  2022cites this paper
• Association of HIV Infection With Cardiovascular Pathology Based on Advanced Cardiovascular Imaging: A Systematic Review.

  2022cites this paper
• The Association of Gestational Diabetes with HIV Infection and Tuberculosis in Indian Women.

  2022cites this paper
• Trends in diabetes incidence and associated risk factors among people with HIV in the current treatment era

  2022cites this paper
• Prevalence and risk factors of high cholesterol and triglycerides among people with HIV in Texas

  2022cites this paper
• Effectiveness of a 6-Month Nutrition Intervention in People Living with HIV and Prediabetes Progressing through Stages of Change towards Positive Health Behavior

  2022cites this paper
• Association of Cumulative Viral Load With the Incidence of Hypertension and Diabetes in People With HIV

  2022cites this paper
• Clonal hematopoiesis in men living with HIV and association with subclinical atherosclerosis

  2022cites this paper
• Dyslipidemia and associated risk factors among HIV/AIDS patients on HAART in Asmara, Eritrea

  2022cites this paper